| 查看: 306 | 回复: 1 | |||
zlwcw木虫 (著名写手)
|
[交流]
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies 已有1人参与
|
|
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies SHANGHAI, October 24, 2011 /PRNewswire via COMTEX/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of MedKey Med-Tech Development Co. Ltd. and Jiecheng Med-Tech Development Co. Ltd., two related contract clinical research services companies based in Shanghai, China. The financial terms of the transaction were not disclosed. Founded in 2006, MedKey/Jiecheng have about 80 employees and operate in 15 cities in China, with offices in Shanghai, Beijing, and Guangzhou. The companies provide services in regulatory affairs, Phase I-IV clinical trial management, and clinical trial site management throughout most of the regions in China. Their customer base includes both multinational pharmaceutical companies and domestic Chinese pharmaceutical companies. David Xi, founder, owner, and CEO of the companies, will continue to manage MedKey/Jiecheng as WuXi’s Executive Director of Clinical Operations. As part of WuXi, MedKey/Jiecheng will leverage WuXi’s broad customer base and will focus on clinical services needed by customers for Chinese regulatory filings and market access. “WuXi’s acquisition of Medkey/Jiecheng continues our strategy to build an integrated platform of R&D services that will allow anyone and any company to discover and develop drugs more efficiently and cost effectively for patients,” said Dr. Ge Li, Chairman and CEO of WuXi. “This acquisition provides WuXi an existing clinical development service capability and infrastructure that WuXi will expand and strengthen to serve our customers’ growing clinical development needs in the fast-growing Chinese healthcare market.” |
回复此楼» 猜你喜欢
参比制剂，自己做的PK数据与IF资料报道的数据相差很大
已经有2人回复
-
祈求中本子
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有222人回复
-
脑梗怎么治疗
已经有3人回复
-
脑梗怎么治疗
已经有0人回复
-
各位大佬，H口面上什么时候会评？？？
已经有30人回复
-
生物组织中有目标分析物，专属性怎么做
已经有0人回复
-
2026年山东大学海洋学院生物与医药博士招生-李霞课题组
已经有0人回复
-
博士研究生招生
已经有0人回复
-
药理学、临床药学方向 调剂
已经有1人回复
» 本主题相关价值贴推荐，对您同样有帮助:
lk590
木虫 (著名写手)
- 应助: 24 (小学生)
- 贵宾: 0.452
- 金币: 1667.4
- 散金: 801
- 红花: 18
- 沙发: 2
- 帖子: 1376
- 在线: 272.3小时
- 虫号: 579330
- 注册: 2008-07-04
- 性别: GG
- 专业: 临床药理
2楼2011-10-25 10:47:28
